Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Valbert Oliveira Costa Filho

Showing results (1-10 of 30) with videos related to

Pageof 3
Sort By:
Journal of Gastroenterology and Hepatology|March 19, 2025
Optimizing Model Construction and Ideal Cutoff Mechanisms in Targeted Screening for Autoimmune GastritisPedro Robson Costa Passos, Valbert Oliveira Costa Filho
Journal of Gastroenterology and Hepatology|April 9, 2025
PCED1A as a Predictive Biomarker for Immunotherapy and Anti-Angiogenic Treatment in Hepatocellular and Colorectal CancerValbert Oliveira Costa Filho, Pedro Robson Costa Passos
Metabolism: Clinical and Experimental|June 16, 2025
Expanding the clinical and immunogenomic relevance of SAMD1 in hepatocellular carcinomaValbert Oliveira Costa Filho, Pedro Robson Costa Passos
Revista Da Associacao Medica Brasileira (1992)|July 10, 2025
TSG6 impacts the immune microenvironment and drug sensitivity in gastric cancerValbert Oliveira Costa Filho, Pedro Robson Costa Passos
Einstein (Sao Paulo, Brazil)|August 6, 2025
Precision over quantity: identifying trustworthy genomic risk stratification modelsValbert Oliveira Costa Filho, Pedro Robson Costa Passos
Metabolism: Clinical and Experimental|February 28, 2026
ADH1C as a robust prognostic biomarker in hepatocellular carcinoma: Evidence from a multi-cohort meta-analysisValbert Oliveira Costa Filho, Márcia Valéria Pitombeira, Silvia Helena Barem Rabenhorst
Diabetes Care|September 19, 2025
Methodological Pitfalls in Aggregating Nonstandardized Composite Outcomes in Meta-analyses: Mixing Apples and OrangesPedro Robson Costa Passos, Valbert Oliveira Costa Filho, Mariana Macambira Noronha, et al.
Clinics and Research in Hepatology and Gastroenterology|January 7, 2026
BEND3 Is Associated with Poor Prognosis and Treatment Response in Hepatocellular CarcinomaValbert Oliveira Costa Filho, Pedro Robson Costa Passos, Márcia Valéria Pitombeira Ferreira, et al.
Mycoses|July 2, 2025
Is Antifungal Prophylaxis Needed for Acute Myeloid Leukaemia Patients Treated With Venetoclax-Based Regimens? A Systematic Review and Meta-AnalysisPedro Robson Costa Passos, Valbert Oliveira Costa Filho, Mariana Macambira Noronha, et al.
Journal of Cutaneous Medicine and Surgery|August 11, 2025
Neoadjuvant Immune Checkpoint Inhibitors in CSCC: A Systematic Review and Meta-AnalysisValbert Oliveira Costa Filho, Mariana Macambira Noronha, Pedro Robson Costa Passos, et al.
Pageof 3

Showing results (1-10 of 30) with videos related to

Sort By:
Pageof 3
Journal of Gastroenterology and Hepatology|March 19, 2025
Optimizing Model Construction and Ideal Cutoff Mechanisms in Targeted Screening for Autoimmune GastritisPedro Robson Costa Passos, Valbert Oliveira Costa Filho
Journal of Gastroenterology and Hepatology|April 9, 2025
PCED1A as a Predictive Biomarker for Immunotherapy and Anti-Angiogenic Treatment in Hepatocellular and Colorectal CancerValbert Oliveira Costa Filho, Pedro Robson Costa Passos
Metabolism: Clinical and Experimental|June 16, 2025
Expanding the clinical and immunogenomic relevance of SAMD1 in hepatocellular carcinomaValbert Oliveira Costa Filho, Pedro Robson Costa Passos
Revista Da Associacao Medica Brasileira (1992)|July 10, 2025
TSG6 impacts the immune microenvironment and drug sensitivity in gastric cancerValbert Oliveira Costa Filho, Pedro Robson Costa Passos
Einstein (Sao Paulo, Brazil)|August 6, 2025
Precision over quantity: identifying trustworthy genomic risk stratification modelsValbert Oliveira Costa Filho, Pedro Robson Costa Passos
Metabolism: Clinical and Experimental|February 28, 2026
ADH1C as a robust prognostic biomarker in hepatocellular carcinoma: Evidence from a multi-cohort meta-analysisValbert Oliveira Costa Filho, Márcia Valéria Pitombeira, Silvia Helena Barem Rabenhorst
Diabetes Care|September 19, 2025
Methodological Pitfalls in Aggregating Nonstandardized Composite Outcomes in Meta-analyses: Mixing Apples and OrangesPedro Robson Costa Passos, Valbert Oliveira Costa Filho, Mariana Macambira Noronha, et al.
Clinics and Research in Hepatology and Gastroenterology|January 7, 2026
BEND3 Is Associated with Poor Prognosis and Treatment Response in Hepatocellular CarcinomaValbert Oliveira Costa Filho, Pedro Robson Costa Passos, Márcia Valéria Pitombeira Ferreira, et al.
Mycoses|July 2, 2025
Is Antifungal Prophylaxis Needed for Acute Myeloid Leukaemia Patients Treated With Venetoclax-Based Regimens? A Systematic Review and Meta-AnalysisPedro Robson Costa Passos, Valbert Oliveira Costa Filho, Mariana Macambira Noronha, et al.
Journal of Cutaneous Medicine and Surgery|August 11, 2025
Neoadjuvant Immune Checkpoint Inhibitors in CSCC: A Systematic Review and Meta-AnalysisValbert Oliveira Costa Filho, Mariana Macambira Noronha, Pedro Robson Costa Passos, et al.
Pageof 3